This Solicitation opportunity from Government of Canada was posted on January 8, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Endosafe MCS Endotoxin/Limulus Amebocyte Lysate (LAL) Reagents and Cartridges

Closed

BCPHSA_11331Canada

Submission Closed01/18/2026, 10:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325413

New

DIBBS

REAGENT SET, ANTIBODThe contract pertains to the procurement of a reagent set for antibodies, identified by NSN/Part Number 6550-01-204-5368, with a quantity of one unit requested under purchase request number 7017121423. The solicitation, labeled SPE2DS-26-T-148Q, was posted by the Defense Logistics Agency of the Department of Defense on June 11, 2026, with responses due by June 17, 2026. This contract is a federal solicitation intended for suppliers to provide the specified reagent set, but does not indicate any set-aside type or specify the size or type of business preferred for submission. The contract details include limited information about the place of performance or specific office address, implying that these details may be provided upon award or through direct inquiry. The solicitation is managed by the Defense Logistics Agency, responsible for supplying materials across the Department of Defense. Interested parties can access the complete solicitation documents and respond via the provided DLA Bid System electronic portal, facilitating a competitive procurement process for this specialized reagent set.

Defense Logistics Agency

POSTED

DEADLINE

VITROS 5600 chemistry analyzers with its associated reagents, supplies, and associated supportThe Defense Health Agency is seeking capability statements for a requirement involving the purchase of VITROS 5600 chemistry analyzers along with their associated reagents, supplies, and related support. This sources-sought notice, identified by solicitation number DHA-JB-1, was posted on June 11, 2026, with a response deadline of June 30, 2026. The procurement falls under the North American Industry Classification System (NAICS) code 325413, which pertains to pharmaceutical and medicine manufacturing, although no set-aside applies to this acquisition. The place of performance for this contract will be in Naples, Italy, managed through the agency’s office located in Frederick, Maryland. Interested parties are directed to submit their capability statements according to the instructions provided in the notice, with primary contact for the solicitation being Stacy Ling, reachable via email. This initiative supports the Department of Defense’s efforts to acquire critical laboratory equipment and supplies for medical or diagnostic use within their healthcare facilities.

Defense Health Agency

POSTED

DEADLINE

NOI -Illumina Infinium Methylation Screening ArrayThe National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, has issued a non-competitive combined synopsis/solicitation (number 75N98026Q00600) for the procurement of twenty Infinium Methylation Screening Array-48 Kits from Illumina, Inc. This firm-fixed-price purchase order will support the NHLBI Division of Intramural Research, specifically the Laboratory of Genomic Instability and Cardiopulmonary Outcomes (LoGICO). Illumina is the sole manufacturer of this proprietary BeadChip product, which is protected by patents and trade secrets, and is uniquely compatible with the existing Illumina iScan System and Infinium Automated Pipetting System installed at the NIA Laboratory of Neurogenetics. No other vendor offers a functionally equivalent product, and Illumina has confirmed it has not authorized any intermediaries to supply this item. The acquisition is conducted under the streamlined solicitation authority for commercial items as specified in FAR Subpart 12.6 and FAR 12.603, and it does not exceed the simplified acquisition threshold. It is not set aside for small businesses, falls under NAICS code 325413 for In-Vitro Diagnostic Substance Manufacturing, with a size standard of 1,250 employees. The solicitation incorporates clauses effective through the Federal Acquisition Circular 2026-01. Responses are due by June 18, 2026, and the point of contact for this procurement is Nicholas S. Capobianco of NIH.

National Institutes Of Health Olao

POSTED

DEADLINE

Service-Disabled Veteran-owned Small Business (SDVOSB) certified vendor of Terumo-brand blood collection productsThe Defense Health Agency is conducting a sources sought notice to identify qualified Service-Disabled Veteran-Owned Small Business (SDVOSB) vendors capable of supplying specific Terumo-brand blood collection products. This announcement is strictly for market research purposes and does not constitute a solicitation or a promise to award a contract. Interested parties are required to submit detailed written responses demonstrating their technical expertise, including company information, business certifications, and proof of veteran-owned small business status via the SBA VetCert system. The targeted products include Teruflex 500ml collection bags, Trima Platelet Kits, Isoplate Solution (PAS-F), TSCD wafers, ACD-A Solution 750ml bags, and a 150 mL item with a coupler. Responses must be emailed by 5:00 pm EDT on June 18, 2026, to the designated point of contact at the Defense Health Agency, located at Fort Detrick, Maryland. Participation in this sources sought does not guarantee solicitation issuance or contract award, and no reimbursement will be provided for costs incurred in responding. Businesses must also be registered in the System for Award Management (SAM) and comply with associated certifications. The acquisition falls under NAICS code 325413 with a size standard of 1,250 employees, focusing on in vitro diagnostic substance manufacturing, with no anticipated subcontracting opportunities. The location for performance is in Texas.

Defense Health Agency

POSTED

DEADLINE

TEST KIT, FECAL RAPIThe contract pertains to the procurement of a single unit of a TEST KIT, FECAL RAPI, identified by the NSN/Part Number 6550-01-671-9115. This solicitation, numbered SPE2DS-26-T-147E, was issued by the Defense Logistics Agency under the Department of Defense and was posted on June 10, 2026. Interested parties had until June 16, 2026, to respond to the solicitation. The contract is categorized as a federal procurement opportunity, although no specific socioeconomic set-aside or NAICS code is indicated. The contract details do not specify the exact place of performance or point of contact information, reflecting a broad federal-level procurement. The Defense Logistics Agency, responsible for managing supplies and logistics for the Department of Defense, is the contracting body overseeing the acquisition of this test kit. The procurement likely supports military or federal health and diagnostic needs, aligning with the agency’s mission to provide equipment critical for operational readiness.

Defense Logistics Agency

POSTED

1 day ago

DEADLINE

in 5 days

AI Contract Overview

The Provincial Health Services Authority (PHSA) plans to directly award a five-year contract to Charles River Microbial Solutions International Ltd., located in Wilmington, Massachusetts, to supply Endosafe MCS Endotoxin/Limulus Amebocyte Lysate (LAL) Reagents and Cartridges for the BC Centre for Disease Control. This procurement is identified under solicitation number BCPHSA_11331 and was posted on January 8, 2026, with a response deadline of January 18, 2026. The contract supports the ongoing need for specialized reagents and cartridges essential for endotoxin testing, which is critical for ensuring the safety and quality of medical products within the healthcare system. The contract is managed by PHSA, a federal organization under the Government of Canada, and the primary point of contact for this award is Rizette Cubias, the contracting authority. While the contract specifics, such as the place of performance, are not detailed, the arrangement emphasizes a direct award process, indicating a non-competitive procurement due to the specialized nature of the goods or a preferred supplier relationship. This initiative ensures the BC Centre for Disease Control maintains a reliable supply of these critical testing materials over the contracted term.

General Info

PHSA awards five-year direct contract to Charles River for endotoxin testing reagents and cartridges.

Agency

Government of Canada → Provincial Health Services Authority (Incl. BCCSS)

NAICS

325413 - In-Vitro Diagnostic Substance Manufacturing View NAICS

Place of Performance

CAN

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed

PostedJan 8

Solicitation

Response DeadlineJan 18

Deadline has passed

Submission Closed

01/18/2026, 10:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyGovernment of Canada → Provincial Health Services Authority (Incl. BCCSS)

Contacts1 person available

OfficeN/A

Organization / Agency

Government of Canada → Provincial Health Services Authority (Incl. BCCSS)

Office AddressN/A

Contacts

Rizette CubiasContracting Authority

contact@example.gov

Full Description

Notice is hereby given that Provincial Health Services Authority (“PHSA”), intends to directly award a Contract to the following supplier to provide Endosafe MCS Endotoxin/Limulus Amebocyte Lysate (LAL) Reagents and Cartridges for BC Centre for Disease Control for a term of five (5) years. Charles River Microbial Solutions International Ltd.251 Ballardvale St.,Wilmington, MA,USA 01887